Transient arterial phase respiratory motion-related artifact in MR imaging of the liver: an analysis of four different gadolinium-based contrast agents

Mansi R. Shah, Milana Flusberg, Viktoriya Paroder, Alla Rozenblit, Victoria Chernyak

Research output: Contribution to journalArticle

6 Scopus citations


Purpose The purpose was to compare hepatic arterial phase (HAP) respiratory motion artifact (RMA) between gadoxetate, gadobutrol, gadopentetate, and gadobenate. Materials/methods Two hundred cases of each gadolinium agent were included. RMA was assigned using 5-point Likert scale (1=no motion, 5=extreme motion) on precontrast and HAP. RMA increase (increase ≥1 on HAP from precontrast) was the outcome in logistic regression. Results Odds of RMA increase for gadoxetate were 5.5 (P<.001), 3.6 (P=.034), and 9.5 (P<.001) times higher than gadobutrol, gadopentetate, and gadobenate, respectively. Gadolinium volume and dose were not independent predictors of RMA increase. Conclusion Gadoxetate has increased odds of RMA compared with other gadolinium agents; tight contrast bolus is not a contributor.

Original languageEnglish (US)
Pages (from-to)23-27
Number of pages5
JournalClinical Imaging
Publication statusPublished - Jan 1 2017



  • Gadoxetate
  • Hepatic arterial phase
  • Respiratory motion artifact
  • Transient respiratory motion

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this